CompletedNCT04774926
Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab.
PHASE4 · 122 planned enrolment
- Countries listed
- 1
- Registry update
- May 16, 2025
immortal.lifeVerify the exact trial registrations behind a company, intervention, programme or topic count.
Showing 1–1 of 1. Every record below meets all the filters shown above.
PHASE4 · 122 planned enrolment